📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Hyperhidrosis Treatment Companies

Hyperhidrosis treatment companies specialize in the development and provision of products or services aimed at managing or alleviating excessive sweating, a condition known as hyperhidrosis. These companies may offer medical devices, pharmaceuticals, or other interventions to address the symptoms of hyperhidrosis. 

Hyperhidrosis Treatment Key Companies


Latest Hyperhidrosis Treatment Companies Update

Revance Therapeutics, a pioneer in the field, receives FDA approval for Qbrexza (glycopyrronium) cloth wipes, the first once-daily topical treatment for excessive underarm sweating in adults. This non-invasive option offers a convenient and effective solution for many patients.

Dermira, another key player, announces positive results from a Phase 3 trial of DRM04, a topical cream for axillary hyperhidrosis. This new option, if approved, could expand treatment options for patients seeking non-surgical solutions.

Botanix Pharmaceuticals expects to resubmit its New Drug Application (NDA) for BTXA, a topical botulinum toxin A treatment for underarm hyperhidrosis, in the first quarter of 2024. This potential market entrant could offer a longer-lasting alternative to existing topical options.

List of Hyperhidrosis Treatment Key Companies in the Market

  • Brickell Biotech Inc. (US)

  • Allergan PLC (Ireland)

  • Cynosure (US)

  • Dermira Inc. (US)

  • Dermadry Laboratories inc. (Canada)

  • GlaxoSmithKline PLC (UK)

  • Sesderma (Spain)

  • Miramar Labs Inc. (US)

  • Ulthera Inc. (US)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.